203 related articles for article (PubMed ID: 34108551)
1. Potential natural immunization against atherosclerosis in hibernating bears.
Samal SK; Fröbert O; Kindberg J; Stenvinkel P; Frostegård J
Sci Rep; 2021 Jun; 11(1):12120. PubMed ID: 34108551
[TBL] [Abstract][Full Text] [Related]
2. IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.
Rahman M; Sing S; Golabkesh Z; Fiskesund R; Gustafsson T; Jogestrand T; Frostegård AG; Hafström I; Liu A; Frostegård J
Clin Immunol; 2016 May; 166-167():27-37. PubMed ID: 27102765
[TBL] [Abstract][Full Text] [Related]
3. Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality.
Samal SK; Qureshi AR; Rahman M; Stenvinkel P; Frostegård J
Clin Exp Immunol; 2020 Jul; 201(1):94-104. PubMed ID: 32297318
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against Phosphorylcholine and Malondialdehyde during the First Two Years of Life.
Thiagarajan D; Lundström SL; Pershagen G; Almqvist C; Andolf E; Hedman A; Berg O; Oparina N; Frostegård J
J Immunol; 2020 Oct; 205(8):2109-2116. PubMed ID: 32887753
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D status and bone and connective tissue turnover in brown bears (Ursus arctos) during hibernation and the active state.
Vestergaard P; Støen OG; Swenson JE; Mosekilde L; Heickendorff L; Fröbert O
PLoS One; 2011; 6(6):e21483. PubMed ID: 21731765
[TBL] [Abstract][Full Text] [Related]
6. IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases.
Thiagarajan D; Oparina N; Lundström S; Zubarev R; Sun J; ; Alarcon-Riquelme M; Frostegård J
Sci Rep; 2020 Jul; 10(1):11010. PubMed ID: 32620913
[TBL] [Abstract][Full Text] [Related]
7. Metabolic changes in summer active and anuric hibernating free-ranging brown bears (Ursus arctos).
Stenvinkel P; Fröbert O; Anderstam B; Palm F; Eriksson M; Bragfors-Helin AC; Qureshi AR; Larsson T; Friebe A; Zedrosser A; Josefsson J; Svensson M; Sahdo B; Bankir L; Johnson RJ
PLoS One; 2013; 8(9):e72934. PubMed ID: 24039826
[TBL] [Abstract][Full Text] [Related]
8. Hibernating brown bears are protected against atherogenic dyslipidemia.
Giroud S; Chery I; Arrivé M; Prost M; Zumsteg J; Heintz D; Evans AL; Gauquelin-Koch G; Arnemo JM; Swenson JE; Lefai E; Bertile F; Simon C; Blanc S
Sci Rep; 2021 Sep; 11(1):18723. PubMed ID: 34548543
[TBL] [Abstract][Full Text] [Related]
9. Low cardiac output as physiological phenomenon in hibernating, free-ranging Scandinavian brown bears (Ursus arctos) - an observational study.
Jørgensen PG; Arnemo J; Swenson JE; Jensen JS; Galatius S; Frøbert O
Cardiovasc Ultrasound; 2014 Sep; 12():36. PubMed ID: 25224464
[TBL] [Abstract][Full Text] [Related]
10. Association between dietary and metabolic factors and IgM antibodies to phosphorylcholine and malondialdehyde in patients with systemic lupus erythematosus and population-based matched controls.
Lourdudoss C; Ajeganova S; Frostegård J
Clin Exp Rheumatol; 2018; 36(3):428-433. PubMed ID: 29745894
[TBL] [Abstract][Full Text] [Related]
11. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.
Faria-Neto JR; Chyu KY; Li X; Dimayuga PC; Ferreira C; Yano J; Cercek B; Shah PK
Atherosclerosis; 2006 Nov; 189(1):83-90. PubMed ID: 16386745
[TBL] [Abstract][Full Text] [Related]
12. IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors.
Sun J; Lundström SL; Zhang B; Zubarev RA; Steuer J; Gillgren P; Rahman M; Ajeganova S; Liu A; Frostegård J
Atherosclerosis; 2018 Jan; 268():36-48. PubMed ID: 29175653
[TBL] [Abstract][Full Text] [Related]
13. Brown bears (Ursus arctos) seem resistant to atherosclerosis despite highly elevated plasma lipids during hibernation and active state.
Arinell K; Sahdo B; Evans AL; Arnemo JM; Baandrup U; Fröbert O
Clin Transl Sci; 2012 Jun; 5(3):269-72. PubMed ID: 22686205
[TBL] [Abstract][Full Text] [Related]
14. Seasonal variation in haematological and biochemical variables in free-ranging subadult brown bears (Ursus arctos) in Sweden.
Græsli AR; Evans AL; Fahlman Å; Bertelsen MF; Blanc S; Arnemo JM
BMC Vet Res; 2015 Dec; 11():301. PubMed ID: 26646442
[TBL] [Abstract][Full Text] [Related]
15. Vasculoprotective properties of plasma lipoproteins from brown bears (Ursus arctos).
Pedrelli M; Parini P; Kindberg J; Arnemo JM; Bjorkhem I; Aasa U; Westerståhl M; Walentinsson A; Pavanello C; Turri M; Calabresi L; Öörni K; Camejo G; Fröbert O; Hurt-Camejo E
J Lipid Res; 2021; 62():100065. PubMed ID: 33713671
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against Phosphorylcholine among New Guineans Compared to Swedes: An Aspect of the Hygiene/Missing Old Friends Hypothesis.
Frostegård J; Tao W; Råstam L; Lindblad U; Lindeberg S
Immunol Invest; 2017 Jan; 46(1):59-69. PubMed ID: 27611006
[TBL] [Abstract][Full Text] [Related]
17. Why are brown bears protected against atherosclerosis even though their plasma cholesterol levels are twice that of humans?
Hurt-Camejo E; Pedrelli M
Clin Investig Arterioscler; 2022; 34(6):322-325. PubMed ID: 36307326
[TBL] [Abstract][Full Text] [Related]
18. Body temperature during hibernation is highly correlated with a decrease in circulating innate immune cells in the brown bear (Ursus arctos): a common feature among hibernators?
Sahdo B; Evans AL; Arnemo JM; Fröbert O; Särndahl E; Blanc S
Int J Med Sci; 2013; 10(5):508-14. PubMed ID: 23532623
[TBL] [Abstract][Full Text] [Related]
19. Pronounced expression of the lipolytic inhibitor G0/G1 Switch Gene 2 (G0S2) in adipose tissue from brown bears (Ursus arctos) prior to hibernation.
Jessen N; Nielsen TS; Vendelbo MH; Viggers R; Støen OG; Evans A; Frøbert O
Physiol Rep; 2016 Apr; 4(8):. PubMed ID: 27117803
[TBL] [Abstract][Full Text] [Related]
20. Hibernation and plasma lipids in free-ranging brown bears-implications for diabetes.
Tekin H; Frøbert O; Græsli AR; Kindberg J; Bilgin M; Buschard K
PLoS One; 2023; 18(9):e0291063. PubMed ID: 37669305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
